UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (507) 507
Patent (6) 6
Book / eBook (5) 5
Book Chapter (4) 4
Publication (3) 3
Streaming Video (2) 2
Web Resource (2) 2
Conference Proceeding (1) 1
Government Document (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (263) 263
life sciences & biomedicine (233) 233
humans (211) 211
hematology (128) 128
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (101) 101
oncology (100) 100
imatinib mesylate (84) 84
biological and medical sciences (83) 83
medical sciences (81) 81
benzamides (72) 72
leukemia, myelogenous, chronic, bcr-abl positive - genetics (67) 67
female (63) 63
hemic and lymphatic diseases (63) 63
abridged index medicus (62) 62
fusion proteins, bcr-abl - genetics (62) 62
hematologic and hematopoietic diseases (61) 61
male (60) 60
animals (59) 59
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (57) 57
mutation (54) 54
chronic myeloid leukemia (53) 53
adult (52) 52
middle aged (51) 51
antineoplastic agents (48) 48
antineoplastic agents - therapeutic use (47) 47
protein kinase inhibitors - therapeutic use (47) 47
mice (46) 46
aged (45) 45
protein kinase inhibitors - pharmacology (45) 45
leukemia (42) 42
pyrimidines - pharmacology (42) 42
pyrimidines - therapeutic use (40) 40
piperazines - pharmacology (39) 39
piperazines - therapeutic use (38) 38
antineoplastic agents - pharmacology (36) 36
fusion proteins, bcr-abl - antagonists & inhibitors (36) 36
leukemia, myelogenous, chronic, bcr-abl positive - pathology (36) 36
pharmacology. drug treatments (35) 35
drug resistance, neoplasm (33) 33
cell line, tumor (31) 31
protein-tyrosine kinases - antagonists & inhibitors (31) 31
treatment outcome (31) 31
drug therapy (30) 30
fusion proteins, bcr-abl - metabolism (30) 30
imatinib (28) 28
research (28) 28
aged, 80 and over (27) 27
analysis (27) 27
drug resistance, neoplasm - genetics (27) 27
cancer (26) 26
genetic aspects (26) 26
physical sciences (25) 25
tumors (25) 25
tyrosine (24) 24
prognosis (22) 22
leukemia, myelogenous, chronic, bcr-abl positive - enzymology (21) 21
philadelphia chromosome (21) 21
bcr-abl (20) 20
dasatinib (20) 20
care and treatment (19) 19
hematology, oncology and palliative medicine (19) 19
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (19) 19
cell biology (18) 18
chemotherapy (18) 18
apoptosis - drug effects (17) 17
dose-response relationship, drug (17) 17
kinases (17) 17
myeloid leukemia (17) 17
protein structure, tertiary (17) 17
chromosome aberrations (16) 16
cml (16) 16
fusion proteins, bcr-abl (16) 16
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (15) 15
patients (15) 15
antineoplastic agents - administration & dosage (14) 14
follow-up studies (14) 14
fusion proteins, bcr-abl - chemistry (14) 14
health aspects (14) 14
medical genetics (14) 14
myeloid neoplasia (14) 14
neoplasms (14) 14
phosphorylation (14) 14
protein-tyrosine kinases - genetics (14) 14
drug resistance, neoplasm - drug effects (13) 13
geology (13) 13
k562 cells (13) 13
pyrimidines - administration & dosage (13) 13
signal transduction (13) 13
time factors (13) 13
tumor cells, cultured (13) 13
antineoplastic agents - adverse effects (12) 12
cell proliferation - drug effects (12) 12
medicine (12) 12
medicine, research & experimental (12) 12
molecular targeted therapy (12) 12
piperazines - administration & dosage (12) 12
protein kinase inhibitors - adverse effects (12) 12
proteins (12) 12
research & experimental medicine (12) 12
stem cells (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 22, pp. 2075 - 2088
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Amylases - blood | Lipase - blood | Follow-Up Studies | Humans | Middle Aged | Imidazoles - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Imidazoles - administration & dosage | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Drug Resistance, Neoplasm | Male | Structure-Activity Relationship | Antineoplastic Agents - administration & dosage | Dose-Response Relationship, Drug | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Protein-Tyrosine Kinases - genetics | Antineoplastic Agents - adverse effects | Pyridazines - administration & dosage | Aged, 80 and over | Adult | Female | Pyridazines - adverse effects | Imidazoles - adverse effects | Antineoplastic Agents - chemistry | Pancreatitis - chemically induced | Pyridazines - chemistry | Fusion Proteins, bcr-abl - genetics | Fusion Proteins, bcr-abl - antagonists & inhibitors | Aged | Mutation | Protein-Tyrosine Kinases - antagonists & inhibitors | Patient outcomes | BCR-ABL tyrosine kinase inhibitors | Dosage and administration | Genetic aspects | Acute lymphocytic leukemia | Research | Drug therapy | Tyrosine | BCR protein | Acute lymphatic leukemia | Myeloid leukemia | Leukemia | Pancreatitis | Abl protein | Chronic myeloid leukemia | Lymphatic leukemia | Lipase | Kinases | Philadelphia chromosome | Proteins | Myelosuppression | Fusion protein | Protein-tyrosine kinase | Binding sites | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2013, Volume 368, Issue 19, pp. 1781 - 1790
Journal Article
Journal Article
The New England journal of medicine, ISSN 0028-4793, 12/2019, Volume 381, Issue 24, pp. 2315 - 2326
Journal Article
Cancer cell, ISSN 1535-6108, 2009, Volume 16, Issue 5, pp. 401 - 412